Cargando…
Callosal circularity as an early marker for Alzheimer's disease
BACKGROUND: Although brain atrophy is considered to be a downstream marker of Alzheimer's disease (AD), subtle changes may allow to identify healthy subjects at risk of developing AD. As the ability to select at-risk persons is considered to be important to assess the efficacy of drugs and as M...
Autores principales: | Van Schependom, Jeroen, Niemantsverdriet, Ellis, Smeets, Dirk, Engelborghs, Sebastiaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029557/ https://www.ncbi.nlm.nih.gov/pubmed/29984160 http://dx.doi.org/10.1016/j.nicl.2018.05.018 |
Ejemplares similares
-
Reliability of measuring regional callosal atrophy in neurodegenerative diseases
por: Van Schependom, Jeroen, et al.
Publicado: (2016) -
Automated MRI volumetry as a diagnostic tool for Alzheimer's disease: Validation of icobrain dm
por: Struyfs, Hanne, et al.
Publicado: (2020) -
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
por: Niemantsverdriet, Ellis, et al.
Publicado: (2017) -
A simulation study on the impact of the blood flow-dependent component in [(18)F]AV45 SUVR in Alzheimer’s disease
por: Ottoy, Julie, et al.
Publicado: (2017) -
Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer’s Disease
por: Niemantsverdriet, Ellis, et al.
Publicado: (2016)